The Brazil pet veterinary drugs market is expected to expand at a CAGR of 7.1%

Posted May 2, 2018 by nirajresearchnester

The Brazil pet veterinary drugs market is expected to expand at a CAGR of 7.1% during the forecast period of 2017-2024

Brazil Pet Veterinary Drugs Market Overview

Veterinary drugs are basically used for the treatment of numerous diseases in pets. Further, rise in the number of pet ownership has been witnessed in recent years. Likely, the number of pet ownership is anticipated to increase as companion animals provide positive health benefits such as low blood pressure, reduced anxiety, affectionate response and improved well-being. Moreover, pet owners are more concerned about health and welfare of their pets owing to the continued strengthening of the bond between pet owners and their companion animals. These factors demonstrate the willingness of animal owners to pay for veterinary drugs, considering the welfare of the animals.

Further, the companies are working to develop innovative veterinary drugs for the treatment of animals. Likely, rising number of serious diseases among pet animals such as foot and mouth diseases, ringworm and others are encouraging the companies to develop and introduce innovative animal drugs in order to increase their lives and improve the quality of life. These innovative products will boost the demand for veterinary drug products. Moreover, penetration of internet into the life of the people has changed the way of business. Various pharmacy companies are supplying the pet veterinary drugs and vaccines to the consumers through online shopping. The online platforms serve a dual purpose of selling as well as advertisement of the product.

Veterinary drug manufacturers are heavily investing in R&D and working on the development of innovative and efficacy pet veterinary drugs. The presence of supportive government regulation and increasing ownership of pet is creating opportunities for the market players to introduce new and innovative products into the market. Furthermore, the top companies are committed to massive R&D in order to ensure their large term competitiveness.

Market Size and Forecast

The Brazil pet veterinary drugs market is expected to expand at a CAGR of 7.1% during the forecast period of 2017-2024. Further, the demand for parasiticides is expected to dominate in the conditions segment and is anticipated to have a share of more than 41% by 2024. Moreover, by vaccines segment, the demand for recombinant vaccines is estimated to remain highest due to the prevalence of pet diseases coupled with increasing number of pet population in Brazil. Further, availability of diversified parasiticides drugs is providing specific solutions to the diseases in pets.

In Brazil, State of Rio Grande Do Sul dominated the Brazil pet veterinary drugs market in 2016. Further, the state is projected to continue its dominance over the forecast period i.e. 2017-2024. Sao Paulo is projected to witness a robust growth in pet veterinary drugs market by the end of 2024 owing to the high adoption rate of pets in the state. Further, continuous strengthened bond between pet and pet owners and high disposable income is believed to increase the demand for pet veterinary drugs in the Sao Paulo.

Request For Sample Pages:

Further, Santa Catarina, Parana, Sao Paulo and Rio Grande Do Sul are expected to be the biggest market for Brazil pet veterinary drugs over the forecast period 2017-2024.

Market Segmentation:
Our in-depth analysis of the Brazil pet veterinary drugs includes the following segments:
By Oral Drugs
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
Feed Additives
Amino Acids
By Conditions
By Route of Administration
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Drug Stores
By States
Sao Paulo
Minas Gerais
Rio De Janeiro
Rio Grande Do Sul
Santa Catarina
Espirito Santo
Rio Grande Do Norte
Mato Grosso
Distrito Federal
Mato Grosso Do Sul

Growth Drivers and Challenges:

Rising incidences of infections and diseases in pet animals are the major factors behind the growth of pet veterinary drugs market. Further, pet diseases and infections have the risk of being transmitted to humans. This factor is spurring the demand for pet veterinary drugs as associated infections and diseases can be life-threating. Moreover, the infection rate among pet animals has been continuously increasing. This is expected to increase the demand for the antibacterial and anti-parasitic veterinary drugs in the upcoming years.
Furthermore, the trend of adoption of pets is increasing the risk of diseases transmitted to humans by animals. Rising government regulations to protect humans from animal transferable disease are opening the opportunities for the pet pharmaceutical drugs manufacturers to develop and introduce various products to control the disease. In addition to this, defined standards by the government healthcare agencies ensure the quality, safety and efficacy of animal health care products and to prevent the penetration of substandard veterinary drugs in the market. This factor is increasing the market revenue of organized players and encouraging them to develop and launch new and innovative animal healthcare products.

Request Ask The Analyst: -

Moreover, approval of various drugs by the government pharmaceutical licensing agency in the previous years indicates the attractiveness of animal healthcare business segment. Further, this has given rise to set up of various veterinary research institutes in the region.

However, the high cost of the development of the pet veterinary drugs further increase the overall cost of drugs which is hampering the growth of the pet veterinary drugs market. Further, recent economic recession in Brazil has slowed the growth of pet veterinary drugs market in the country. Moreover, lack of awareness about animal welfare medications, zoonosis medications and food safety medications is likely to dampen the market growth of pet veterinary drugs market across the globe.

Key Players
Bayer Animal Health
Company Overview
Key Product Offerings
Business Strategy
SWOT Analysis
Ceva Animal Healthcare
Elanco Animal Health
Merck Ltd.
Zoetis Animal Healthcare
Virbac do Brasil Industria e Comercio Ltda
Merial Animal Health
J.A. Animal Health
Scope and Contexts
Overview of the Parent Market
Analyst View
The Brazil pet veterinary drugs market is segmented as follows:
By Oral Drugs Market Size & Y-O-Y Growth Analysis
By Conditions Market Size & Y-O-Y Growth Analysis
By Route of Administration Market Size & Y-O-Y Growth Analysis
By Distribution Channel Market Size & Y-O-Y Growth Analysis
By States Market Size & Y-O-Y Growth Analysis
Market Dynamics
Supply & Demand Risk
Competitive Landscape
Porter’s Five Force Model
Geographical Economic Activity
Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and Challenges
Key Information for Players to establish themselves in current dynamic environment

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Read More Information:
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Ajay Daniel
Country United States
Categories Health , Medical , News
Tags Brazil Pet Veterinary Drugs Market Size , Brazil Pet Veterinary Drugs Market news , Brazil Pet Veterinary Drugs Market Demand , Brazil Pet Veterinary Drugs Market Research , Brazil Pet Veterinary Drugs Market Growth
Last Updated May 2, 2018